Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 9/20 | 0.47 |
| ▸ | HINT1 | P49773 | 3/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PNP | P00491 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 2/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21474244 | 1.00 | STING1 (0.47) | STING1HINT1NT5EFUT5HPGD | |
| SCHEMBL21489453 | 0.92 | HINT1 (0.43) | STING1HINT1NT5EFUT5HPGD | |
| SCHEMBL21473292 | 0.91 | STING1 (0.41) | STING1HINT1NT5EHPGD | |
| SCHEMBL21474251 | 0.91 | HINT1 (0.51) | STING1HINT1NT5EFUT5PNP | |
| SCHEMBL21504573 | 0.89 | STING1 (0.49) | STING1HINT1NT5EFUT5PNP | |
| SCHEMBL21489169 | 0.89 | STING1 (0.51) | STING1HINT1NT5EFUT5PNP | |
| SCHEMBL21473303 | 0.89 | STING1 (0.51) | STING1HINT1NT5EFUT5PNP | |
| SCHEMBL26189229 | 0.88 | STING1 (0.50) | STING1HINT1NT5EFUT5HPGD | |
| SCHEMBL24377171 | 0.86 | STING1 (0.49) | STING1HINT1NT5EFUT5HPGD | |
| SCHEMBL20547910 | 0.86 | STING1 (0.49) | STING1HINT1NT5EFUT5HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242569-A1 | PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242569-A1 | PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | PPIP5K2, INPP5B, PTMS | STING1 4287/4885HINT1 1295/4885NT5E 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.